CompaniesAcelity

Acelity

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

0

As Collaborator

6

Total Enrollment

4,506

By Phase

NA: 5

By Status

UNKNOWN: 3COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT03773575
NCT03816293
NCT05041244
NCT04214236
NCT04539015
NCT04677166
Hover over trial bars to see details

Recent Trials

NCT04677166Collaborator
Coupling Negative Pressure Wound Therapy With Instillation
NATerminated
6 participants
Started: Jan 19, 2021 · Completed: Oct 21, 2024
NCT04539015Collaborator
Assess the Efficacy of Prevena Plus vs SOC to Closed Incision in Pts Undergoing CAWR and Other Laparotomy Procedures.
N/AUnknown
170 participants
Started: Jul 9, 2020 · Completed: Feb 28, 2023
NCT04214236Collaborator
CiNPT for Abdominoplasties in Post-bariatric Patients Study
NAUnknown
130 participants
Started: Feb 1, 2020 · Completed: Jan 31, 2023
NCT03816293Collaborator
SUpPress SSI - Single Use Negative Pressure Wound Therapy (NPWT) to Reduce Surgical Site Infections
NACompleted
3,680 participants
Started: May 1, 2019 · Completed: Sep 30, 2021
NCT05041244Collaborator
Negative Pressure Wound Therapy in Diabetic Wounds
NACompleted
80 participants
Started: May 1, 2019 · Completed: Jul 1, 2021
View all 6 trials →
Funding History (2)
S-1/A
Oct 7, 2015
Filing
S-1
Aug 26, 2015
Filing
Acelity | Biotech Hunter | Biotech Hunter